Effect of tauro-alpha-muricholate and tauro-beta-muricholate on oestradiol-17 beta-glucuronide-induced cholestasis in rats

J Gastroenterol Hepatol. 1997 Jan;12(1):84-6. doi: 10.1111/j.1440-1746.1997.tb00352.x.

Abstract

The effect of tauro-beta-muricholate (beta MC-tau) and tauro-alpha-muricholate (alpha MC-tau) on oestradiol-17 beta-glucuronide (E217G)-induced cholestasis was compared with that of tauroursodeoxycholate (UDC-tau) in rats. Like UDC-tau, alpha MC-tau and beta MC-tau infused at the rate of 0.2 mumol/min per 100 g bodyweight (BW) completely inhibited the cholestasis induced by E217G infused at the rate of 0.06 mumol/min per 100 g BW for 20 min. These findings indicate that beta MC-tau and alpha MC-tau are useful in protecting against various types of experimental cholestasis, as well as against bile acid-induced cholestasis.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Cholestasis / chemically induced*
  • Cholestasis / prevention & control*
  • Estradiol / analogs & derivatives*
  • Isomerism
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Taurochenodeoxycholic Acid / pharmacology*
  • Taurocholic Acid / analogs & derivatives*
  • Taurocholic Acid / pharmacology

Substances

  • estradiol-17 beta-glucuronide
  • tauromuricholic acid
  • Estradiol
  • Taurochenodeoxycholic Acid
  • Taurocholic Acid
  • ursodoxicoltaurine